The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas

The oncogenic transcription factor Myc is required for the progression and maintenance of diverse tumors. This has led to the concept that Myc itself, Myc-activated gene products, or associated biological processes might constitute prime targets for cancer therapy. Here, we present an in vivo revers...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: D'Andrea, Aleco, Gritti, Ilaria, Nicoli, Paola, Giorgio, Marco, Doni, Mirko, Conti, Annalisa, Bianchi, Valerio, Casoli, Lucia, Sabò, Arianna, Mironov, Alexandre, Beznoussenko, Galina V., Amati, Bruno
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Priority Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341918/
https://ncbi.nlm.nih.gov/pubmed/27635472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11719
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia